Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.29 CNY -4.61% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Kanion Pharmaceutical Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Total Current Assets
ÂĄ3.9B
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
8%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Current Assets
ÂĄ28.9B
CAGR 3-Years
19%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Current Assets
ÂĄ15.1B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Current Assets
ÂĄ34.8B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
18%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Current Assets
ÂĄ36.4B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
12%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Current Assets
ÂĄ775.8m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Kanion Pharmaceutical Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Pharmaceuticals

Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.

Intrinsic Value
23.69 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Total Current Assets?
Total Current Assets
3.9B CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Total Current Assets amounts to 3.9B CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
8%

Over the last year, the Total Current Assets growth was 3%. The average annual Total Current Assets growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been 14% over the past three years , 6% over the past five years , and 8% over the past ten years .

Back to Top